Kallyope snags $21 mln


New York City-based Kallyope Inc., a biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, has secured $21 million in funding. The lead investor was Bill Gates. Other investors included Lux Capital, The Column Group, Polaris Partners, Illumina Ventures, Alexandria Venture Investments, Euclidean Capital and Two Sigma Ventures.

Source: Press Release